UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The American journal of medicine, ISSN 0002-9343, 02/2020, Volume 133, Issue 2, pp. 182 - 185
Heart failure | Cardiovascular outcomes trials | Glucose-lowering therapy | Diabetes mellitus | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Agents - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Humans | Heart Failure - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2020, Volume 382, Issue 17, pp. 1653 - 1659
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pandemics | Down-Regulation | Humans | Angiotensin Receptor Antagonists - pharmacology | Hypertension - drug therapy | Renal Insufficiency, Chronic - complications | Betacoronavirus - metabolism | Renal Insufficiency, Chronic - drug therapy | COVID-19 | Pneumonia, Viral - metabolism | Angiotensin-Converting Enzyme 2 | SARS-CoV-2 | Coronavirus Infections - metabolism | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Pneumonia, Viral - complications | Peptidyl-Dipeptidase A - metabolism | Coronavirus Infections - complications | Hypertension - complications | Renin-Angiotensin System - drug effects | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Angiotensin Receptor Antagonists - therapeutic use | Control | Physiological aspects | Development and progression | Research | Renin-angiotensin system | ACE inhibitors | Risk factors | Hypertension | Enzymes | Peptides | Risk groups | Cardiovascular disease | Coronaviruses | Aldosterone | Angiotensin-converting enzyme 2--ACE2 | Severe acute respiratory syndrome coronavirus 2 | Proteins | Renin | Illnesses | Lungs | Peptidyl-dipeptidase A | Coronary vessels | Angiotensin | Physiology | Viral infections | Index Medicus | Abridged Index Medicus
Journal Article
JAMA cardiology, ISSN 2380-6583, 07/2020, Volume 5, Issue 7, pp. 831 - 840
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | COVID-19 | SARS-CoV-2 | Cardiovascular Diseases - virology | Pandemics | Humans | Pneumonia, Viral - complications | Betacoronavirus | Cardiovascular Diseases - epidemiology | Coronavirus Infections - complications | Pneumonia, Viral - mortality | Coronavirus Infections - mortality | Index Medicus
Journal Article
JACC. Heart failure, ISSN 2213-1779, 02/2019, Volume 7, Issue 2, pp. 169 - 172
heart failure | diabetes mellitus | comorbidities | prevention | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Failure - prevention & control | Cardiologists - standards | Global Health | Comorbidity | Humans | Sodium-Glucose Transporter 2 Inhibitors - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Heart Failure - epidemiology | Drug Prescriptions - standards | Diabetes Mellitus, Type 2 - epidemiology | Practice Guidelines as Topic
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2012, Volume 60, Issue 20, pp. 2082 - 2089
Cardiovascular | Internal Medicine | heart failure | spironolactone | renal dysfunction | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart failure | Enzymes | Care and treatment | Enzyme inhibitors | Spironolactone | Cardiac patients | Angiotensin | Antiandrogens | Heart attack | Pharmacy | Drugstores | Hypertension | Heart attacks | Mortality | Medical prognosis | Hospitalization | Diabetes | Drug therapy | Potassium
Journal Article
European heart journal, ISSN 0195-668X, 2017, Volume 38, Issue 5, pp. 334 - 337
Journal Article
JACC. Heart failure, ISSN 2213-1779, 12/2014, Volume 2, Issue 6, pp. 663 - 670
neprilysin | heart failure | natriuretic peptide | Heart failure | Natriuretic peptide | Neprilysin | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Biomarkers - metabolism | Peptide Fragments - metabolism | Humans | Natriuretic Peptide, Brain - metabolism | Hypertension - drug therapy | Clinical Trials as Topic | Antihypertensive Agents - therapeutic use | Aminobutyrates - therapeutic use | Heart Failure - drug therapy | Neprilysin - antagonists & inhibitors | Renin-Angiotensin System - drug effects | Tetrazoles - therapeutic use | Hypertension - mortality | Drug Therapy, Combination | Angiotensin Receptor Antagonists - therapeutic use | Heart Failure - mortality
Journal Article
JACC. Heart failure, ISSN 2213-1779, 02/2019, Volume 7, Issue 2, pp. 118 - 120
Journal Article
Pharmacogenomics, ISSN 1462-2416, 11/2016, Volume 17, Issue 16, pp. 1817 - 1858
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cytochrome P-450 CYP2D6 - genetics | Pharmacogenetics | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Humans | Receptors, Adrenergic, beta-1 - genetics | Adrenergic beta-Antagonists - therapeutic use | Heart Failure - drug therapy | Polymorphism, Genetic
Journal Article
10.
Full Text
Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis
Journal of general internal medicine : JGIM, ISSN 0884-8734, 11/2020, Volume 35, Issue 11, pp. 3323 - 3332
Health Care Sciences & Services | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Falls (Accidents) | Aged | Mortality | Analysis | Decision support systems | Intervention | Bias | Cognitive ability | Clinical trials | Risk | Hospitalization | Quality of life | Reviews | Education | Older people | Adults | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2012, Volume 60, Issue 20, pp. 2082 - 2089
heart failure | spironolactone | renal dysfunction | Cardiology. Vascular system | Heart | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Length of Stay | Prognosis | Double-Blind Method | Diuretics - pharmacology | Humans | Risk Factors | Heart Failure - physiopathology | Male | Treatment Outcome | Hospitalization | Heart Failure - drug therapy | Glomerular Filtration Rate - drug effects | Spironolactone - pharmacology | Diuretics - therapeutic use | Female | Spironolactone - therapeutic use | Heart Failure - mortality | Index Medicus | Abridged Index Medicus
Journal Article
JAMA cardiology, ISSN 2380-6583, 11/2020
Journal Article
Heart rhythm, ISSN 1547-5271, 11/2020, Volume 17, Issue 11, pp. 1930 - 1935
Drugs | Long QT syndrome | Drug-induced arrhythmia | Electrocardiogram | Mortality | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Pandemics | Rheumatic Diseases - drug therapy | Antirheumatic Agents - administration & dosage | Risk Adjustment | Coronavirus Infections - drug therapy | Humans | Middle Aged | Pneumonia, Viral - drug therapy | Long QT Syndrome - chemically induced | Male | Drug Monitoring - methods | Hydroxychloroquine - adverse effects | Minnesota - epidemiology | COVID-19 | Renal Insufficiency, Chronic - epidemiology | Long QT Syndrome - diagnosis | SARS-CoV-2 | Rheumatic Diseases - mortality | Antirheumatic Agents - adverse effects | Betacoronavirus | Female | Retrospective Studies | Electrocardiography - methods | Outcome and Process Assessment, Health Care | Long QT Syndrome - epidemiology | Risk Factors | Electrocardiography - statistics & numerical data | Hydroxychloroquine - administration & dosage | Atrial Fibrillation - epidemiology | Index Medicus
Journal Article